The Maryland Stem Cell Research Act of 2006 (the Act) established and funded a Stem Cell Research Fund to promote state-funded stem cell research and cures through grants and loans to public and private entities in the State. The fund is a special, nonlapsing fund that is not subject to the State Finance and Procurement Article. Funding to date is $38 million (FY2007 and FY2008). Additional funding is dependent upon State appropriations.

The Maryland Stem Cell Research Commission is an independent body whose members include the Attorney General or designee, patient advocates, individuals with experience in biotechnology, scientists from the University System of Maryland and Johns Hopkins University, and bioethicists. The Commission adopts regulations that ensure that adult stem cell and stem cell research financed by the Fund complies with State law; develops criteria, standards, and requirements for the initial review of grant applications; establishes procedures and guidelines to be used by an independent Scientific Peer Review Committee (SPRC); determines what types of grants or other forms of funding to award, as well as the size, duration, objectives and terms of all such grants; and makes the decisions about which grants should be recommended for awards, based on both the scientific rankings of the SPRC for grants and on certain broader policy considerations set forth in Maryland’s Stem Cell Act.

The Commission functions within the Maryland Technology Development Corporation (TEDCO). TEDCO, created by the State legislature in 1998, is a public instrumentality of the State. Governed by a 15-member Board appointed by the Governor with the advice and consent of the Senate, the Board is comprised of leaders in the State’s technology community and contains representatives from the private, university, non-profit, and public sectors.

Grants have been awarded for the FY2007 and FY2008; for the list of awardees, please visit

Grants have been awarded for FY2009; for more information and a list of awardess, please visit

Contact for IASCR: Dan Gincel, Ph.D., Director, Maryland Stem Cell Research Fund